Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-in Capital	Accumulated Other Comprehensive (Loss) Income	Accumulated Deficit
Beginning balance at Dec. 31, 2023	$ 125,704	$ 45	$ 411,821	$ 63	$ (286,225)
Beginning Balance, Shares at Dec. 31, 2023		44,754,853
Issuance of common stock in private placement, net of offering costs	39,172	$ 9	39,163
Issuance of common stock in private placement, net of offering costs (Shares)		8,849,371
Issuance of common stock pursuant to at-the-market (ATM) program, net of offering costs (See Note 14)	10,590	$ 4	10,586
Issuance of common stock pursuant to at-the-market (ATM) program, net of offering costs (See Note 14) (Shares)		3,600,000
Issuance of pre-funded warrants in private placement, net of offering costs	7,700		7,700
Issuance of restricted common stock, net of tax withholdings	(196)	$ 1	(197)
Issuance of restricted common stock, net of tax withholdings, (Shares)		1,497,921
Stock options exercised	245		245
Stock options exercised (Shares)		100,981
Stock-based compensation	4,320		4,320
Net unrealized loss on marketable debt securities	(123)			(123)
Net loss	(3,256)				(3,256)
Ending balance at Mar. 31, 2024	184,156	$ 59	473,638	(60)	(289,481)
Ending balance (in shares) at Mar. 31, 2024		58,803,126
Beginning balance at Dec. 31, 2024	120,751	$ 60	484,077	170	(363,556)
Beginning Balance, Shares at Dec. 31, 2024		59,967,814
Exercise of pre-funded warrants	2	$ 2
Exercise of pre-funded warrants (Shares)		1,611,215
Issuance of restricted common stock, net of tax withholdings	(2)		(2)
Issuance of restricted common stock, net of tax withholdings, (Shares)		22,728
Issuance of common stock under employee stock purchase plan ("ESPP") (Shares)		29,619
Stock-based compensation	3,631		3,631
Net unrealized loss on marketable debt securities	(121)			(121)
Net loss	(21,158)				(21,158)
Ending balance at Mar. 31, 2025	$ 103,103	$ 62	$ 487,706	$ 49	$ (384,714)
Ending balance (in shares) at Mar. 31, 2025		61,631,376